Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal, registrational Phase 3 DIAGNODE-3 trial in type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback